Aridis Pharmaceuticals Operating Expenses 2011-2026 | ARDS

Annual Operating Expenses Aridis Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	23.4 K	30.1 M	26.9 M	20.6 M	8.23 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
30.1 M	23.4 K	17.2 M

Quarterly Operating Expenses Aridis Pharmaceuticals

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.29 M	-	7.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
7.81 M	1.29 M	4.55 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Alector ALEC	177 M	$ 2.11	-13.17 %	$ 217 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Apellis Pharmaceuticals APLS	948 M	$ 20.52	-2.12 %	$ 2.59 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Axsome Therapeutics AXSM	99.1 M	$ 164.13	0.15 %	$ 8.17 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aytu BioScience AYTU	53.7 M	$ 2.49	-3.11 %	$ 15.6 M	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
BridgeBio Pharma BBIO	304 M	$ 64.24	-3.37 %	$ 12.3 B	USA
BioAtla BCAB	130 M	$ 0.18	-26.92 %	$ 8.6 M	USA
BioCardia BCDA	15.7 M	$ 1.37	6.2 %	$ 29 M	USA
BioCryst Pharmaceuticals BCRX	144 M	$ 8.61	-1.66 %	$ 1.78 B	USA
Black Diamond Therapeutics BDTX	78.8 M	$ 2.4	-3.04 %	$ 132 M	USA
Beam Therapeutics BEAM	523 M	$ 28.29	-0.6 %	$ 2.8 B	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.07 B	$ 11.47	-0.43 %	$ 742 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Biogen BIIB	5.39 B	$ 187.68	-2.16 %	$ 27.5 B	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
BioVie BIVI	18.1 M	$ 1.38	-0.01 %	$ 2.04 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.91	2.83 %	$ 908 M	Israel
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 60.68	-1.7 %	$ 11.6 B	USA
Bristol-Myers Squibb Company BMY	12.2 B	$ 62.54	0.27 %	$ 127 B	USA
Benitec Biopharma BNTC	9.83 M	$ 10.85	-0.5 %	$ 447 M	USA
BioNTech SE BNTX	512 M	$ 109.85	-0.34 %	$ 27.2 B	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
BioXcel Therapeutics BTAI	107 M	$ 1.63	-2.69 %	$ 4.13 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Burford Capital Limited BUR	106 M	$ 8.6	1.9 %	$ 1.39 B	Britain
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA